Sotera Health Debt to Equity Ratio 2019-2026 | SHC
Current and historical debt to equity ratio values for Sotera Health (SHC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Sotera Health debt/equity for the three months ending June 30, 2026 was 3.33.
| Sotera Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-06-30 | $2.64B | $0.67B | 3.97 |
| 2026-03-31 | $2.61B | $0.62B | 4.20 |
| 2025-12-31 | $2.66B | $0.61B | 4.38 |
| 2025-09-30 | $2.64B | $0.55B | 4.79 |
| 2025-06-30 | $2.71B | $0.51B | 5.29 |
| 2025-03-31 | $2.68B | $0.41B | 6.48 |
| 2024-12-31 | $2.67B | $0.41B | 6.59 |
| 2024-09-30 | $2.68B | $0.47B | 5.70 |
| 2024-06-30 | $2.64B | $0.42B | 6.23 |
| 2024-03-31 | $2.63B | $0.43B | 6.13 |
| 2023-12-31 | $2.69B | $0.44B | 6.06 |
| 2023-09-30 | $2.66B | $0.38B | 7.05 |
| 2023-06-30 | $2.66B | $0.42B | 6.35 |
| 2023-03-31 | $3.05B | $0.36B | 8.45 |
| 2022-12-31 | $2.77B | $0.35B | 7.90 |
| 2022-09-30 | $2.20B | $0.61B | 3.63 |
| 2022-06-30 | $2.20B | $0.64B | 3.47 |
| 2022-03-31 | $2.19B | $0.64B | 3.42 |
| 2021-12-31 | $2.20B | $0.59B | 3.76 |
| 2021-09-30 | $2.22B | $0.53B | 4.22 |
| 2021-06-30 | $2.33B | $0.52B | 4.45 |
| 2021-03-31 | $2.31B | $0.47B | 4.96 |
| 2020-12-31 | $2.31B | $0.46B | 5.07 |
| 2020-09-30 | $0.00B | $0.00B | 0.00 |
| 2020-06-30 | $0.00B | $0.00B | 0.00 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $3.22B | $-0.64B | -5.03 |
| 2018-12-31 | $2.66B | $0.05B | 58.54 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.516B | $1.164B |
| Sotera Health Company is a provider of mission-critical end-to-end sterilization solutions and lab testing as well as advisory services for the healthcare industry. The company market through businesses which include Sterigenics(R), Nordion(R) and Nelson Labs(R). Sotera Health Company is Sotera Health Company is based in CLEVELAND. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.474B | 25.66 |
| CVS Health (CVS) | United States | $117.307B | 11.70 |
| HCA Healthcare (HCA) | United States | $93.189B | 14.49 |
| Elevance Health (ELV) | United States | $89.472B | 14.04 |
| Cencora (COR) | United States | $60.778B | 18.57 |
| Natera (NTRA) | United States | $49.779B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.318B | 18.55 |
| Viatris (VTRS) | United States | $19.549B | 6.75 |
| Medpace Holdings (MEDP) | United States | $17.206B | 36.13 |
| DiDi Global (DIDIY) | China | $16.502B | 181.00 |
| Revvity (RVTY) | United States | $16.261B | 27.24 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.991B | 0.00 |
| Solventum (SOLV) | United States | $15.121B | 12.51 |
| ICON (ICLR) | Ireland | $13.318B | 18.10 |
| Charles River Laboratories (CRL) | United States | $13.052B | 27.62 |
| BrightSpring Health Services (BTSG) | United States | $11.666B | 40.11 |
| Avantor (AVTR) | United States | $10.558B | 19.04 |
| BioMerieux (BMXMF) | France | $9.856B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.972B | 78.36 |
| HealthEquity (HQY) | United States | $7.941B | 25.88 |
| Sonic Healthcare (SKHHY) | Australia | $6.793B | 0.00 |
| PACS (PACS) | United States | $6.761B | 22.72 |
| GETINGE (GNGBY) | Sweden | $6.602B | 18.65 |
| MiniMed (MMED) | United States | $6.302B | 0.00 |
| CochLear (CHEOY) | Australia | $6.298B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.100B | 23.07 |
| Concentras Parent (CON) | United States | $4.638B | 22.87 |
| Organon (OGN) | United States | $3.590B | 4.56 |
| GeneDx Holdings (WGS) | United States | $2.905B | 270.61 |
| CareDx (CDNA) | United States | $2.770B | 315.00 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.123B | 12.44 |
| Establishment Labs Holdings (ESTA) | United States | $2.121B | 0.00 |
| Progyny (PGNY) | United States | $2.101B | 29.76 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.911B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.895B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.824B | 69.65 |
| Alignment Healthcare (ALHC) | United States | $1.807B | 45.84 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.692B | 10.16 |
| Freenome (FRNM) | United States | $1.583B | 0.00 |
| Ardent Health (ARDT) | United States | $1.512B | 8.65 |
| Agilon Health (AGL) | United States | $1.506B | 0.00 |
| Nutex Health (NUTX) | United States | $1.488B | 8.53 |
| InnovAge Holding (INNV) | United States | $1.481B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| Omada Health (OMDA) | United States | $1.210B | 247.00 |
| Teladoc Health (TDOC) | United States | $1.168B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.161B | 22.60 |
| CryoPort (CYRX) | United States | $0.836B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.701B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.462B | 0.00 |
| SBC Medicals (SBC) | United States | $0.461B | 9.53 |
| Forward Industries (FWDI) | United States | $0.444B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.387B | 5.62 |
| Shoulder Innovations (SI) | United States | $0.372B | 0.00 |
| Biodesix (BDSX) | United States | $0.301B | 0.00 |
| Embecta (EMBC) | United States | $0.291B | 2.51 |
| So-Young (SY) | China | $0.285B | 0.00 |
| LifeMD (LFMD) | United States | $0.155B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.097B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.071B | 8.37 |
| Tevogen (TVGN) | United States | $0.051B | 0.00 |
| DocGo (DCGO) | United States | $0.038B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |